186 related articles for article (PubMed ID: 3061921)
1. T-cell lymphoma: morphology, immunophenotype and clinical features.
Krajewski AS; Myskow MW; Cachia PG; Salter DM; Sheehan T; Dewar AE
Histopathology; 1988 Jul; 13(1):19-41. PubMed ID: 3061921
[TBL] [Abstract][Full Text] [Related]
2. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.
LeBlanc RE; Lefterova MI; Suarez CJ; Tavallaee M; Kim YH; Schrijver I; Kim J; Gratzinger D
Hum Pathol; 2015 Sep; 46(9):1382-9. PubMed ID: 26193796
[TBL] [Abstract][Full Text] [Related]
3. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
Bosisio FM; Cerroni L
Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous T cell lymphomas: mycosis fungoides, Sezary syndrome and HTLV-I-associated adult T cell leukemia (ATL) in Mali, West Africa: a clinical, pathological and immunovirological study of 14 cases and a review of the African ATL cases.
Fouchard N; Mahe A; Huerre M; Fraitag S; Valensi F; Macintyre E; Sanou F; de The G; Gessain A
Leukemia; 1998 Apr; 12(4):578-85. PubMed ID: 9557617
[TBL] [Abstract][Full Text] [Related]
5. Non lymphoblastic T cell lymphomas with prevalent skin involvement different from mycosis fungoides or Sézary's syndrome. A retrospective study of 6 cases in Europe.
Grob JJ; Horchowski N; Tubiana N; Gabriel B; Gastaut JA; Hassoun J; Jouve I; Carcassone Y; Bonerandi JJ
Dermatologica; 1988; 177(2):82-97. PubMed ID: 3262542
[TBL] [Abstract][Full Text] [Related]
6. Lymph node classification systems in cutaneous T-cell lymphoma. Evidence for the utility of the Working Formulation of Non-Hodgkin's Lymphomas for Clinical Usage.
Vonderheid EC; Diamond LW; van Vloten WA; Scheffer E; Meijer CJ; Cashell AW; Hardman JM; Lai SM; Hermans J; Matthews MJ
Cancer; 1994 Jan; 73(1):207-18. PubMed ID: 8275427
[TBL] [Abstract][Full Text] [Related]
7. [Lymph node localization of epidermotropic T malignant lymphomas (mycosis fungoides and Sézary's syndrome)].
Wechsler J; Diebold J; Gérard-Marchant R
Bull Cancer; 1984; 71(2):89-99. PubMed ID: 6610451
[TBL] [Abstract][Full Text] [Related]
8. Follicular center helper T-cell (TFH) marker positive mycosis fungoides/Sezary syndrome.
Meyerson HJ; Awadallah A; Pavlidakey P; Cooper K; Honda K; Miedler J
Mod Pathol; 2013 Jan; 26(1):32-43. PubMed ID: 22918164
[TBL] [Abstract][Full Text] [Related]
9. Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas.
Weiss LM; Crabtree GS; Rouse RV; Warnke RA
Am J Pathol; 1985 Feb; 118(2):316-24. PubMed ID: 3155915
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
Edelson RL
J Am Acad Dermatol; 1980 Feb; 2(2):89-106. PubMed ID: 6988470
[TBL] [Abstract][Full Text] [Related]
11. Immunopathology of non-Hodgkin lymphomas.
Huber H; Gattringer C; Knapp W; Stein H
Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous lymphomas in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): A series of 12 cases.
Liu YA; Finn AJ; Subtil A
J Cutan Pathol; 2021 May; 48(5):617-624. PubMed ID: 33415780
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic and immunologic features associated with transformation of mycosis fungoides to large-cell lymphoma.
Cerroni L; Rieger E; Hödl S; Kerl H
Am J Surg Pathol; 1992 Jun; 16(6):543-52. PubMed ID: 1599034
[TBL] [Abstract][Full Text] [Related]
14. Incidence and ten-year follow-up of primary cutaneous lymphomas: a single-centre cohort study.
Maurelli M; Tessari G; Colato C; Schena D; Girolomoni G
Eur J Dermatol; 2018 Feb; 28(1):44-49. PubMed ID: 29171395
[TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous lymphomas: the analysis of cases treated in the Department of Dermatology University Hospital in Krakow.
Spałkowska M; Brzewski P; Walter S; Jaworek AK; Sułowicz J; Andres M; Wojas-Pelc A
Przegl Lek; 2016; 73(7):452-9. PubMed ID: 29676886
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical characterisation of cutaneous lymphomas other than mycosis fungoides.
Ralfkiaer E; Saati TA; Bosq J; Delsol G; Gatter KC; Mason DY
J Clin Pathol; 1986 May; 39(5):553-63. PubMed ID: 3522633
[TBL] [Abstract][Full Text] [Related]
17. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
18. Mycosis fungoides and Sézary syndrome in Japan. Clinicopathologic study of 107 autopsy cases.
Arai E; Katayama I; Ishihara K
Pathol Res Pract; 1991 May; 187(4):451-7. PubMed ID: 1876527
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous T-cell lymphoma: a review.
Winkler CF; Bunn PA
Crit Rev Oncol Hematol; 1983; 1(1):49-92. PubMed ID: 6083835
[TBL] [Abstract][Full Text] [Related]
20. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
